美国 · 股市与财经 · Quartz

Viatris is buying Pacira BioSciences for $1.65 billion in non-opioid pain push

来源：Quartz · 美国 40 分钟前

The deal, at $36.50 per share, represents a roughly 45% premium and is expected to close by the end of 2026

在 Quartz 阅读全文登录后可收藏

MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (qz.com)

推荐阅读

Judge Extends Pause on Trump’s Ban Against CNN, MS NOW and Politico

Business Insider

I always thought I'd settle down in Canada. Living in Japan for a year changed my mind.

Apple appoints new M&A chief under CEO Ternus: report

Watch the trailer for ‘The Altruists,’ Netflix’s show about the FTX scandal

Here’s what happened in crypto today

Solana DeFi Firms Orca and Loopscale Merge Under New Formation Brand